Macroscopic extent of gastric mucosal atrophy: increased risk factor for esophageal squamous cell carcinoma in Japan
暂无分享,去创建一个
Hirokazu Takahashi | H. Kirikoshi | A. Nakajima | K. Kubota | Y. Rino | K. Hosono | M. Inamori | M. Yoneda | Hiroki Endo | Hiroshi Iida | K. Fujita | K. Yoneda | N. Kobayashi | Y. Abe | S. Saito | Tomoyuki Akiyama | A. Goto
[1] Hirokazu Takahashi,et al. Risk Factors for the Progression of Endoscopic Barrett’s Epithelium in Japan: A Multivariate Analysis Based on the Prague C & M Criteria , 2009, Digestive Diseases and Sciences.
[2] T. Rokkas,et al. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[3] P. Hainaut,et al. Epidemiology of oesophagogastric cancer , 2007 .
[4] E. Cutsem. The multidisciplinary management of gastrointestinal cancer , 2007 .
[5] T. Shimosegawa,et al. Extensive Gastric Atrophy: An Increased Risk Factor for Superficial Esophageal Squamous Cell Carcinoma in Japan , 2007, The American Journal of Gastroenterology.
[6] Michael Vieth,et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.
[7] N. Ishimura,et al. Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype , 2006, Scandinavian journal of gastroenterology.
[8] Jang-Ming Lee,et al. Helicobacter pylori Infection: A Protective Factor for Esophageal Squamous Cell Carcinoma in a Taiwanese Population , 2005, The American Journal of Gastroenterology.
[9] Joseph K McLaughlin,et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. , 2004, Journal of the National Cancer Institute.
[10] C. Hamashima,et al. Mortality trend of esophageal cancer in Japan: 1960-2000. , 2003, Japanese journal of clinical oncology.
[11] M. Hongo. Nocturnal gastric acid breakthrough may not be a problem of acid secretion only , 2003, Journal of Gastroenterology.
[12] J. Virtamo,et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[13] M. Hongo,et al. Epidemiology of reflux disease and CLE in East Asia. , 2002, Journal of gastroenterology.
[14] G. Berglund,et al. Helicobacter pylori Infection is Associated with a Decreased Risk of Developing Oesophageal Neoplasms , 2001, Helicobacter.
[15] L. Hansson,et al. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. , 2001, Gastroenterology.
[16] C. Mowat,et al. Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. , 2000, Gastroenterology.
[17] T. Koike,et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylorieradication , 2000, Gut.
[18] T. Koike,et al. A new endoscopic method of gastric acid secretory testing , 1998, American Journal of Gastroenterology.
[19] Y. Shiratori,et al. Major virulence factors, VacA and CagA, are commonly positive inHelicobacter pylori isolates in Japan , 1998, Gut.
[20] E. El-Omar,et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. , 1997, Gastroenterology.
[21] D. Graham,et al. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. , 1997, Scandinavian journal of gastroenterology.
[22] J R Bennett,et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. , 1996, Gastroenterology.
[23] E. Kuipers,et al. Helicobacter pylori and atrophic gastritis: importance of the cagA status. , 1996, Journal of the National Cancer Institute.
[24] M. Blaser,et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[25] E. El-Omar,et al. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. , 1993, Gut.
[26] T C Campbell,et al. Geographic association between urinary excretion of N‐nitroso compounds and oesophageal cancer mortality in china , 1993, International journal of cancer.
[27] D. Graham,et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. , 1992, Gastroenterology.
[28] J. Fraumeni,et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.
[29] C. McConkey,et al. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. , 1990, British Journal of Cancer.
[30] Kenji Takahashi,et al. Serum pepsinogens as a screening test of extensive chronic gastritis , 1987, Gastroenterologia Japonica.
[31] T. Takemoto,et al. An Endoscopic Recognition of the Atrophic Border and its Significance in Chronic Gastritis , 1969 .
[32] P. Hainaut,et al. The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer. , 2007, Best practice & research. Clinical gastroenterology.
[33] R. Stockbrügger,et al. Bacteria in the aetio-pathogenesis of gastric cancer: a review. , 1995, Scandinavian journal of gastroenterology. Supplement.